Kristi A. H. Elliott
About Kristi A. H. Elliott
Chief Science Officer at Capricor
Kristi A. H. Elliott serves as the Chief Science Officer at Capricor, a role she has held since joining the company in 2021. She is responsible for overseeing Capricor's exosome platform and pipeline development. Her leadership in this area aligns with her extensive background in biotechnology, particularly in the realms of stem cell knowledge and exosome platform development.
Education and Academic Qualifications
Kristi A. H. Elliott earned her B.A. in biology and M.S. in molecular biology from Rutgers University. She then went on to receive her Ph.D. in human genetics and molecular biology from The Johns Hopkins School of Medicine. These academic qualifications underpin her expertise in stem cell and exosome development.
Biotechnology Career and Previous Roles
Kristi A. H. Elliott has over 15 years of experience in the biotechnology industry. Before her current role at Capricor, she served as the Vice President of Research and Development. She also provided technical advice in Business Development and Strategy for Exotech Bio and AD Skincare. At Intrexon Corp., she held several key positions including Senior Director of Stem Cell and Exosome Development and Director of the Human Therapeutics Division.
Expertise in Exosome Platform Development
Kristi A. H. Elliott has extensive experience in exosome platform development. She has been involved in the conception and implementation of processes related to exosome purification, scale-up, loading, and targeting. Her work includes overseeing multiple exosome-based product candidates through their development stages.
Early Career and Specialization
Kristi A. H. Elliott began her career as a stem cell specialist at the University of California, Irvine. Her early specialization in stem cells has been a cornerstone of her career, contributing to her subsequent roles and achievements in both stem cell therapeutics and exosome-based research programs.